Skip to main content
Clinical Trials/IRCT20211109053019N1
IRCT20211109053019N1
Recruiting
Phase 3

Evaluation the effect of Tranexamic acid infusion with oxytocin versus oxytocin alone before elective cesarean section in prevention preoperative and post operative hemorrhage in Karaj Kamali Hospital: A randomized clinical trial study

Karaj University of Medical Sciences0 sites200 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Post partum hemorrhage after elective cesarean section.
Sponsor
Karaj University of Medical Sciences
Enrollment
200
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Karaj University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Singleton pregnancy
  • Age over 18 years old
  • Gestational age over 34 weeks
  • Hemoglobin level before operation over 10 mg/dl
  • Platelets over 100000
  • Be an elective cesarean section candidate

Exclusion Criteria

  • Emergency cesarean section
  • Age less than 18 years old
  • History of deep vein thrombosis or pulmonary emboli
  • History of arterial thrombosis( pectoralis angina, myocardial infarction or stroke)
  • History of convulsion or epilepsy
  • Any known active cardiovascular or liver or kidney disorder
  • Autoimmune disease
  • Sickle cell disease
  • Severe bleeding disease
  • Placenta previa

Outcomes

Primary Outcomes

Not specified

Similar Trials